Literature DB >> 2356857

Effects of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney.

J J Creely1, S J DiMari, A M Howe, C P Hyde, M A Haralson.   

Abstract

Studies were performed to characterize the effects of both acute and chronic exposure to epidermal growth factor (EGF) on collagen biosynthesis by NRK52E cells, an epithelioid line established from normal rat kidney. Both conditions of exposure to EGF stimulated cell growth. Qualitative analysis revealed that NRK52E cells continued to synthesize types I, III, IV, and V collagens under all circumstances. However, both acute and chronic exposure to EGF increased two- to fourfold the amounts of collagenous proteins secreted by NRK52E cells, but decreased by 40 to 80% the amounts of collagenous material derived from the cell layers. Quantitative evaluation of type I and type III molecules confirmed that both conditions of exposure to EGF resulted in substantial increases in the amounts of these types of collagen secreted by the cells. However, analysis of the cell-associated types I and III molecules revealed that, while prolonged exposure to EGF significantly decreased the production of both types of collagen, acute exposure minimally affected type I collagen levels, but decreased type III production greater than 40%. Thus, conditions of acute exposure resulted in a slight increase in the total amount of type I collagen produced, but a slight decrease in the amount of type III collagen synthesized. In contrast, chronic exposure to EGF decreased the total amount of both collagen types synthesized, with type III being decreased to a greater extent (approximately 70%) than was type I (approximately 50%). Thus, the ratio of type III to type I collagen produced by NRK52E cells was decreased under both conditions of exposure to EGF. Therefore, these studies establish that EGF can modify matrix production in an epithelioid line of renal origin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356857      PMCID: PMC1877575     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Growth factor regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-I, acidic and basic fibroblast growth factor, and transforming growth factor-beta in serum free culture.

Authors:  S Kanda; K Nomata; P K Saha; N Nishimura; J Yamada; H Kanatake; Y Saito
Journal:  Cell Biol Int Rep       Date:  1989-08

Review 2.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation.

Authors:  J E de Larco; G J Todaro
Journal:  J Cell Physiol       Date:  1978-03       Impact factor: 6.384

4.  The estimation of two collagens from human dermis by interrupted gel electrophoresis.

Authors:  B Sykes; B Puddle; M Francis; R Smith
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

5.  Epidermal growth factor stimulates collagen synthesis in liver-derived epithelial clone cells.

Authors:  M Kumegawa; T Yajima; M Hiramatsu; E Ikeda; K Hatakeyama; M Namba
Journal:  Biochim Biophys Acta       Date:  1981-07

6.  Human glomerular cells in vitro: isolation and characterization.

Authors:  G E Striker; P D Killen; F M Farin
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

7.  Collagen synthesis by human glomerular cells in culture.

Authors:  J I Scheinman; D M Brown; A F Michael
Journal:  Biochim Biophys Acta       Date:  1978-08-03

8.  Human glomerular visceral epithelial cells synthesize a basal lamina collagen in vitro.

Authors:  P D Killen; G E Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Alterations in the extracellular matrix components in human glomerular diseases.

Authors:  A Oomura; T Nakamura; M Arakawa; A Ooshima; M Isemura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Proliferative glomerulonephritis in rats: evidence that mononuclear phagocytes infiltrating the glomeruli stimulate the proliferation of endothelial and mesangial cells.

Authors:  C H Dubois; J B Foidart; M B Hautier; C A Dechenne; M J Lemaire; P R Mahieu
Journal:  Eur J Clin Invest       Date:  1981-04       Impact factor: 4.686

View more
  6 in total

1.  Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells.

Authors:  J J Creely; S J DiMari; A M Howe; M A Haralson
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion.

Authors:  Guillermo Petrini; Elena J Ochoa; Esteban Serra; Adriana M Torres; M Monica Elías
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

3.  Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Authors:  F Terzi; M Burtin; M Hekmati; P Federici; G Grimber; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis.

Authors:  Jukka M Rintala; Johanna Savikko; Sini E Rintala; Niina Palin; Petri K Koskinen
Journal:  J Nephrol       Date:  2015-09-30       Impact factor: 3.902

Review 5.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

6.  Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury.

Authors:  T Homma; M Sakai; H F Cheng; T Yasuda; R J Coffey; R C Harris
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.